Covid-19: Gilead's remdesivir gets India nod for restricted emergency use



India's drug regulator has granted US pharma giant Gilead Sciences marketing authorisation for its anti-viral drug remdesivir for "restricted emergency use" on hospitalised Covid-19 patients in view of the crisis posed by the pandemic.
The approval process for remdesivir was accelerated in view of the emergency situation and the unmet need for medicines in light of the coronavirus outbreak, a source in the know of the developments told PTI.
The drug has been allowed for restricted emergency use for treatment of suspected or laboratory-confirmed cases of Covid-19 in adults and children hospitalised with severe symptoms, subject to several safeguards, the source said. Read More

Comments

Popular posts from this blog

Cafe Coffee Day names S V Ranganath as interim chairman

Flag at half mast: India in 7-day state mourning for Pranab Mukherjee.

Samsung to launch Galaxy M30 with three rear cameras, 5000mAh battery today